Victorian QuickFire Challenge: Driving Device Innovation
最多可达300,000*
Winners
- Atmo Biosciences：总部位于澳大利亚的Atmo Biosciences已开发出一种专利的，低成本的非侵入性医疗设备，形式是可耐用的电子胶囊。该设备从肠道中从气体浓度中收集数字健康数据，以筛查和诊断胃肠道疾病，并评估饮食治疗对肠道的影响。
- RMIT大学：An Australia-based RMIT University team led by Madhu Bhaskaran has developed electronics that stretch and flex, driving the development of ultra-light, stretchable, wearable sensors. The team’s transparent, unbreakable patch has been demonstrated for ultra-violet (UV) sensing and can be potentially integrated with clothing or worn on skin. The patch can quantitatively track the amount of UV radiation and exposure (both UVA and UVB).
- Spect Inc.
挑战
Medical Device Innovators are invited to bring their ideas to the growing hub for scientific innovation in the state of Victoria, Australia through the Victorian QuickFire Challenge: Driving Device Innovation. Victoria has one of the world's largest life science clusters composed of medtech, biotech and pharmaceutical industries. The sector employs more than 23,000 people and is made up of more than 650 firms ranging in size from small start-ups to large Victorian exporters and global manufacturers. Revenue in the sector has quadrupled since 2003 to $12.7 billion and exports have doubled since 2011 to $1.3 billion.
维多利亚州政府与Johnson＆Johnson Innovation合作宣布的以设备为重点的Quickfire挑战旨在改变Johnson＆Johnson Medical Device Companies的战略性领域，以改变游戏规则的早期医疗设备创新
维多利亚州政府将授予最高300,000澳元的最高解决方案，包括访问设备原型实验室以及Johnson＆Johnson Medical Device专家的指导以及指导。
重点的特定领域包括：
- 3D Printing: Using new technologies to deliver 3-D printing solutions that can have transformative applications
- Biomaterials
- Cardiovascular: Durable, effective interventions to improve outcomes in AFIB and structural heart conditions (e.g. CHF)
- 数字手术：手术机器人技术的新兴技术
- 神经血管：中风患者的创新疗法
- Oncology: Solutions designed to assist with the monitoring, physiotherapy and invasive care of oncology patients
- Obesity: More durable interventions across the continuum, Prevent or reduce morbidities of obesity
- 骨科：联合重建，创伤，脊柱和运动医学。总的来说，这些企业专注于帮助患者进行护理连续性 - 从早期干预到手术替代，目的是帮助人们重返活跃和实现生活。
- Osteoarthritis: Early interventions to prevent progression, Better surgical outcomes in advanced disease
- Osteoporosis: Minimize OP fracture rate, improve healing and address fragile bone
- 传感器技术：可植入和可穿戴的传感器：医疗保健监测的创新方法。
- 手术：推进技术，产品和服务，以增强患者护理，并为手术的各个方面带来更高的精度。
- 想象Care: Creating life-long solutions to vision care needs
为什么这个挑战对我们很重要：
Johnson＆Johnson医疗设备公司在创建新市场，提供突破性创新并建立基于共同愿景建立的强大合作伙伴关系方面拥有成功的历史。我们认为，一个好主意可以来自任何地方，这是我们的目标是打破拥挤的设备景观的噪音，并加速新型技术以为患者提供解决方案的发展。
申请流程：
解决方案将由一组行业和政府审阅者评估其满足以下标准的能力：
- Potential to impact healthcare outcomes in a strategic area of interest
- Uniqueness of solution & level of competition in current market
- 技术的质量和可行性
- Team credibility & capabilities
- Clarity of plan: Milestones & defined go/no go decisions
奖励和利益
- 访问约翰逊和约翰逊创新专家的网络
- *与维多利亚州政府的赠款协议形式，将在医疗设备领域的项目中最多共享300,000澳元的300,000个获奖者，以支付维多利亚州内获得的商品和服务。
Timeline
About Victoria
The Victorian Government is working to sustainably develop the economy by growing employment and improving the lives and prosperity of all Victorians.
自从我们的医疗技术和制药部门战略发布以来，我们通过2亿美元的未来工业基金为行业和制造业提供了关键支持。
Global health care spending is projected to grow by over four per cent per year, so there is an urgent need for new technologies and diagnostic tools that will improve patient care.
通过启动倡议，例如Medtech的Got Talent，新型MedTech执行器和生物保健品，我们正在努力为维多利亚州蓬勃发展的Medtech和制药部门提供这一巨大机会，目前雇用23,000多家，并带来了127亿美元的年收入。
去年，我们在波士顿开设了一个新的维多利亚州政府贸易和投资办公室，以帮助维多利亚州的企业与投资者建立联系，这些投资者可以将有前途的产品和业务理念提升到一个新的水平。
Continuing to grow the sector by attracting talent, supporting start-ups, and strengthening relationships between researchers and global industry will create rewarding, secure jobs for Victorians and help us to play a key role in improving health and wellbeing worldwide.
关于Johnson＆Johnson Innovation, JLABS
Johnson＆Johnson Innovation，JLABS（JLABS）是一个全球开放创新生态系统的网络，使和授权创新者能够为世界各地的患者创造和加速挽救生命，增强生命的健康和健康解决方案。JLABS通过为新兴公司提供最佳环境来实现这一点明天的突破性医疗解决方案。在JLABS，我们珍视伟大的想法，并热衷于消除成功的障碍，以帮助创新者释放其早期科学发现的潜力。JLABS是一个无弦的模型，这意味着企业家可以在坚持其知识产权的同时自由发展科学。JLABS向包括药品，医疗设备，消费者和数字健康部门在内的广泛医疗保健领域开放企业家。
jlabscurrently has locations in innovation hot spots across the world and produces entrepreneurial programs and campaigns to seek out the best science, like the QuickFire Challenges around the globe. The JLABS flagship opened in 2012 in San Diego at Janssen's West Coast Research Center, and since then, has established two locations in San Francisco - one through a collaboration with the California Institute for Quantitative Biosciences (QB3) and a second standalone facility in South San Francisco. JLABS is also located in Boston through a collaboration with LabCentral, in Lowell, Massachusetts through a collaboration with UMass, in Houston through a collaboration with the Texas Medical Center (TMC), in Toronto through a collaboration with the Ontario Government and the University of Toronto. New JLABS in NYC and Shanghai have been announced, and in February 2018, the Belgium-based JLINX incubator began transitioning into a JLABS, making this the first JLABS in Europe. For more information about JLABS, please visitwww.www.2574design.com.
关于Johnson＆Johnson Innovation
ld乐动Johnson＆Johnson Innovation LLC致力于加快全球创新的所有阶段，并在企业家和Johnson＆Johnson的全球医疗保健业务之间建立合作。Johnson＆Johnson Innovation为科学家，企业家和新兴公司提供一站式访问科学和技术专家，他们可以促进约翰逊和约翰逊的药品，医疗设备和消费者公司的合作。在Johnson＆Johnson Innovation的业务雨伞下，我们通过区域创新中心与创新者（Johnson＆Johnson Innovation）与创新者联系|Jlabs，Johnson＆Johnson Innovation -JJDC，Inc。和我们的业务开发团队创建定制的交易和新颖合作，以加快创新发展以解决患者的未满足需求。有关更多信息，请访问www.jnjinnovation.com或关注@jnjinnovation。
Proudly supported by the Victorian Government